These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18548199)

  • 61. A new family of densely functionalized fused-benzoquinones as potent human protein kinase CK2 inhibitors.
    Martín-Acosta P; Haider S; Amesty Á; Aichele D; Jose J; Estévez-Braun A
    Eur J Med Chem; 2018 Jan; 144():410-423. PubMed ID: 29288942
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of cultured human astrocytes and vascular endothelial cells with protein kinase CK2 inhibitors induces early changes in cell shape and cytoskeleton.
    Kramerov AA; Golub AG; Bdzhola VG; Yarmoluk SM; Ahmed K; Bretner M; Ljubimov AV
    Mol Cell Biochem; 2011 Mar; 349(1-2):125-37. PubMed ID: 21125314
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Unexpected CK2β-antagonistic functionality of bisubstrate inhibitors targeting protein kinase CK2.
    Pietsch M; Viht K; Schnitzler A; Ekambaram R; Steinkrüger M; Enkvist E; Nienberg C; Nickelsen A; Lauwers M; Jose J; Uri A; Niefind K
    Bioorg Chem; 2020 Mar; 96():103608. PubMed ID: 32058103
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Structure-activity relationship study of 4-(thiazol-5-yl)benzoic acid derivatives as potent protein kinase CK2 inhibitors.
    Ohno H; Minamiguchi D; Nakamura S; Shu K; Okazaki S; Honda M; Misu R; Moriwaki H; Nakanishi S; Oishi S; Kinoshita T; Nakanishi I; Fujii N
    Bioorg Med Chem; 2016 Mar; 24(5):1136-41. PubMed ID: 26850376
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Novel indeno[1,2-b]indoloquinones as inhibitors of the human protein kinase CK2 with antiproliferative activity towards a broad panel of cancer cell lines.
    Hundsdörfer C; Hemmerling HJ; Hamberger J; Le Borgne M; Bednarski P; Götz C; Totzke F; Jose J
    Biochem Biophys Res Commun; 2012 Jul; 424(1):71-5. PubMed ID: 22728884
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Halogenated benzimidazoles and benzotriazoles as inhibitors of the NTPase/helicase activities of hepatitis C and related viruses.
    Borowski P; Deinert J; Schalinski S; Bretner M; Ginalski K; Kulikowski T; Shugar D
    Eur J Biochem; 2003 Apr; 270(8):1645-53. PubMed ID: 12694177
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Structure-based identification of novel CK2 inhibitors with a linear 2-propenone scaffold as anti-cancer agents.
    Qi X; Zhang N; Zhao L; Hu L; Cortopassi WA; Jacobson MP; Li X; Zhong R
    Biochem Biophys Res Commun; 2019 Apr; 512(2):208-212. PubMed ID: 30878184
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Kinase CK2 inhibition: an update.
    Cozza G; Pinna LA; Moro S
    Curr Med Chem; 2013; 20(5):671-93. PubMed ID: 23210774
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Casein kinase-II inhibition promotes retinal ganglion cell survival and axonal regeneration.
    Cen LP; Liu YF; Ng TK; Luo JM; van Rooijen N; Zhang M; Pang CP; Cui Q
    Exp Eye Res; 2018 Dec; 177():153-159. PubMed ID: 30118655
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT.
    Yde CW; Frogne T; Lykkesfeldt AE; Fichtner I; Issinger OG; Stenvang J
    Cancer Lett; 2007 Oct; 256(2):229-37. PubMed ID: 17629615
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Protein kinase CK2 regulates metal toxicity in neuronal cells.
    Zaman MS; Johnson AJ; Bobek G; Kueh S; Kersaitis C; Bailey TD; Buskila Y; Wu MJ
    Metallomics; 2016 Jan; 8(1):82-90. PubMed ID: 26623569
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Major tegument protein VP8 of bovine herpesvirus 1 is phosphorylated by viral US3 and cellular CK2 protein kinases.
    Labiuk SL; Babiuk LA; van Drunen Littel-van den Hurk S
    J Gen Virol; 2009 Dec; 90(Pt 12):2829-2839. PubMed ID: 19692545
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Synthesis and physico-chemical properties in aqueous medium of all possible isomeric bromo analogues of benzo-1H-triazole, potential inhibitors of protein kinases.
    Wąsik R; Wińska P; Poznański J; Shugar D
    J Phys Chem B; 2012 Jun; 116(24):7259-68. PubMed ID: 22632480
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In Silico and In Vitro Studies of Natural Compounds as Human CK2 Inhibitors.
    Haidar S; Jürgens F; Aichele D; Jose J
    Curr Comput Aided Drug Des; 2021; 17(2):323-331. PubMed ID: 32160849
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of 4,5,6,7-tetrahalogeno-1H-isoindole-1,3(2H)-diones as inhibitors of human protein kinase CK2.
    Golub AG; Yakovenko OY; Prykhod'ko AO; Lukashov SS; Bdzhola VG; Yarmoluk SM
    Biochim Biophys Acta; 2008 Jan; 1784(1):143-9. PubMed ID: 18021749
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells.
    Trembley JH; Unger GM; Korman VL; Tobolt DK; Kazimierczuk Z; Pinna LA; Kren BT; Ahmed K
    Cancer Lett; 2012 Feb; 315(1):48-58. PubMed ID: 22050909
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'.
    Bollacke A; Nienberg C; Borgne ML; Jose J
    J Pharm Biomed Anal; 2016 Mar; 121():253-260. PubMed ID: 26786382
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diversity-oriented synthesis of pyrazolo[4,3-b]indoles by gold-catalysed three-component annulation: application to the development of a new class of CK2 inhibitors.
    Hou Z; Oishi S; Suzuki Y; Kure T; Nakanishi I; Hirasawa A; Tsujimoto G; Ohno H; Fujii N
    Org Biomol Chem; 2013 May; 11(20):3288-96. PubMed ID: 23535832
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The dark side of protein kinase CK2 inhibition.
    Cozza G; Meggio F; Moro S
    Curr Med Chem; 2011; 18(19):2867-84. PubMed ID: 21651492
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer.
    Bistrović A; Krstulović L; Harej A; Grbčić P; Sedić M; Koštrun S; Pavelić SK; Bajić M; Raić-Malić S
    Eur J Med Chem; 2018 Jan; 143():1616-1634. PubMed ID: 29133046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.